Clonal Markers In Relapsed Acute Promyelocytic Leukemia (APL): Clinicopathological Associations and Relation to All-Trans Retinoic Acid (ATRA) Treatment on Intergroup Phase III Trial C9710
- Citation:
- Blood vol 116 (21) 1038
- Meeting Instance:
- ASH 2010
- Year:
- 2010
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 869
- Program:
- TRP
- Primary Committee:
- Leuk Corr Sci
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- R. E. Gallagher B. K. Moser J. Racevskis X. Poire C. D. Bloomfield A. J. Carroll R. Ketterling D. Ralston E. Schachter-Tokarz D. Zhou I.-M. L. Chen R. Harvey G. Koval D. A. Sher J. H. Feusner M. S. Tallman F. R. Appelbaum R. A. Larson B. L. Powell E. Paietta C. L. Willman W. Stock
- Networks:
- Study
- Alliance-9710
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- Keywords: